Adipose stromal cells-conditioned medium blocks 6-hydroxydopamine-induced neurotoxicity and reactive oxygen species

Neuroscience Letters

Volumn 544, Issue , 2013, Pages 15-19

  Gu, Huiying ^a   Wang, Jimmy ^a   Du, Nicole ^a   Tan, Jiangning ^a   Johnstone, Brian ^a   Du, Yansheng ^a  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

6 OHDA; Antioxidant; Neuronal cell death; Neurons; ROS

Indexed keywords

HYDROGEN PEROXIDE; OXIDOPAMINE; REACTIVE OXYGEN METABOLITE;

ADIPOSE TISSUE CELL; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CELL DEATH; CELL PROTECTION; CEREBELLUM; CONTROLLED STUDY; CULTURE MEDIUM; MESENCEPHALON; MOUSE; NERVE CELL; NEUROPROTECTION; NEUROTOXICITY; NONHUMAN; PRIORITY JOURNAL; STROMA CELL;

ADIPOCYTES; ANIMALS; CELL COMMUNICATION; CELLS, CULTURED; HUMANS; NEURONS; OXIDOPAMINE; RATS; REACTIVE OXYGEN SPECIES; STROMAL CELLS;

EID: 84878395787     PISSN: 03043940     EISSN: 18727972     Source Type: Journal    
DOI: 10.1016/j.neulet.2013.02.057     Document Type: Article

References (47)

1. 2 in chromaffin cells. Eur. J. Pharmacol. 1995, 293:55-64.
2. Andersen J.K. Oxidative stress in neurodegeneration: cause or consequence?. Nat Med 2004, 10(Suppl.):S18-S25.
3. Ashjian P.H., Elbarbary A.S., Edmonds B., DeUgarte D., Zhu M., Zuk P.A., Lorenz H.P., Benhaim P., Hedrick M.H. In vitro differentiation of human processed lipoaspirate cells into early neural progenitors. Plast. Reconstr. Surg. 2003, 111:1922-1931.
4. Bensadoun J.C., Mirochnitchenko O., Inouye M., Aebischer P., Zurn A.D. Attenuation of 6-OHDA-induced neurotoxicity in glutathione peroxidase transgenic mice. Eur. J. Neurosci. 1998, 10:3231-3236.
5. Blum D., Torch S., Lambeng N., Nissou M., Benabid A.L., Sadoul R., Verna J.M. Molecular pathways involved in the neurotoxicity of 6-OHDA, dopamine and MPTP: contribution to the apoptotic theory in Parkinson's disease. Prog. Neurobiol. 2001, 65:135-172.
6. Carvey P.M., Lin D.H., Faselis C.J., Notermann J.K., Ling Z.D. Loss of striatal DA innervation increases striatal trophic activity directed at DA neurons in culture. Exp. Neurol. 1996, 140:184-197.
7. Dodel R.C., Du Y., Bales K.R., Ling Z., Carvey P.M., Paul S.M. Caspase-3-like proteases and 6-hydroxydopamine induced neuronal cell death. Brain Res. Mol. Brain Res. 1999, 64:141-148.
8. Du Y., Dodel R.C., Bales K.R., Jemmerson R., Hamilton-Byrd E., Paul S.M. Involvement of a caspase-3-like cysteine protease in 1-methyl-4-phenylpyridinium-mediated apoptosis of cultured cerebellar granule neurons. J. Neurochem. 1997, 69:1382-1388.
9. Du Y., Ma Z., Lin S., Dodel R.C., Gao F., Bales K.R., Triarhou L.C., Chernet E., Perry K.W., Nelson D.L., Luecke S., Phebus L.A., Bymaster F.P., Paul S.M. Minocycline prevents nigrostriatal dopaminergic neurodegeneration in the MPTP model of Parkinson's disease. Proc. Natl. Acad. Sci. U. S. A. 2001, 98:14669-14674.
10. Ferger B., Teismann P., Mierau J. The dopamine agonist pramipexole scavenges hydroxyl free radicals induced by striatal application of 6-hydroxydopamine in rats: an in vivo microdialysis study. Brain Res. 2000, 883:216-223.
11. Ferger B., Themann C., Rose S., Halliwell B., Jenner P. 6-Hydroxydopamine increases the hydroxylation and nitration of phenylalanine in vivo: implication of peroxynitrite formation. J. Neurochem. 2001, 78:509-514.
12. Fujimura J., Ogawa R., Mizuno H., Fukunaga Y., Suzuki H. Neural differentiation of adipose-derived stem cells isolated from GFP transgenic mice. Biochem. Biophys. Res. Commun. 2005, 333:116-121.
13. Glinka Y., Tipton K.F., Youdim M.B. Nature of inhibition of mitochondrial respiratory complex I by 6-hydroxydopamine. J. Neurochem. 1996, 66:2004-2010.
14. Hamanoue M., Takemoto N., Matsumoto K., Nakamura T., Nakajima K., Kohsaka S. Neurotrophic effect of hepatocyte growth factor on central nervous system neurons in vitro. J. Neurosci. Res. 1996, 43:554-564.
15. Hong S.J., Kihlken J., Choi S.C., March K.L., Lim D.S. Intramyocardial transplantation of human adipose-derived stromal cell and endothelial progenitor cell mixture was not superior to individual cell type transplantation in improving left ventricular function in rats with myocardial infarction. Int. J. Cardiol. 2011.
16. Izumi Y., Sawada H., Sakka N., Yamamoto N., Kume T., Katsuki H., Shimohama S., Akaike A. p-Quinone mediates 6-hydroxydopamine-induced dopaminergic neuronal death and ferrous iron accelerates the conversion of p-quinone into melanin extracellularly. J. Neurosci. Res. 2005, 79:849-860.
17. Jenner P. Oxidative stress in Parkinson's disease. Ann. Neurol. 2003, 53(Suppl. 3):S26-S36. (discussion S36-S28).
18. Jin K., Greenberg D.A. Tales of transdifferentiation. Exp. Neurol. 2003, 183:255-257.
19. Kang S.K., Lee D.H., Bae Y.C., Kim H.K., Baik S.Y., Jung J.S. Improvement of neurological deficits by intracerebral transplantation of human adipose tissue-derived stromal cells after cerebral ischemia in rats. Exp. Neurol. 2003, 183:355-366.
20. Kang S.K., Putnam L.A., Ylostalo J., Popescu I.R., Dufour J., Belousov A., Bunnell B.A. Neurogenesis of Rhesus adipose stromal cells. J. Cell Sci. 2004, 117:4289-4299.
21. Kumar R., Agarwal A.K., Seth P.K. Free radical-generated neurotoxicity of 6-hydroxydopamine. J. Neurochem. 1995, 64:1703-1707.
22. Lin S., Wei X., Xu Y., Yan C., Dodel R., Zhang Y., Liu J., Klaunig J.E., Farlow M., Du Y. Minocycline blocks 6-hydroxydopamine-induced neurotoxicity and free radical production in rat cerebellar granule neurons. Life Sci. 2003, 72:1635-1641.
23. Ma Z.Z., Wei X., Fontanilla C., Noelker C., Dodel R., Hampel H., Du Y. Caffeic acid phenethyl ester blocks free radical generation and 6-hydroxydopamine-induced neurotoxicity. Life Sci. 2006, 79:1307-1311.
24. McCoy M.K., Martinez T.N., Ruhn K.A., Szymkowski D.E., Smith C.G., Botterman B.R., Tansey K.E., Tansey M.G. Blocking soluble tumor necrosis factor signaling with dominant-negative tumor necrosis factor inhibitor attenuates loss of dopaminergic neurons in models of Parkinson's disease. J. Neurosci. 2006, 26:9365-9375.
25. McCoy M.K., Martinez T.N., Ruhn K.A., Wrage P.C., Keefer E.W., Botterman B.R., Tansey K.E., Tansey M.G. Autologous transplants of adipose-derived adult stromal (ADAS) cells afford dopaminergic neuroprotection in a model of Parkinson's disease. Exp. Neurol. 2008, 210:14-29.
26. Nakagami H., Maeda K., Morishita R., Iguchi S., Nishikawa T., Takami Y., Kikuchi Y., Saito Y., Tamai K., Ogihara T., Kaneda Y. Novel autologous cell therapy in ischemic limb disease through growth factor secretion by cultured adipose tissue-derived stromal cells. Arterioscler. Thromb. Vasc. Biol. 2005, 25:2542-2547.
27. Ning H., Lin G., Lue T.F., Lin C.S. Neuron-like differentiation of adipose tissue-derived stromal cells and vascular smooth muscle cells. Differentiation 2006, 74:510-518.
28. Rehman J., Traktuev D., Li J., Merfeld-Clauss S., Temm-Grove C.J., Bovenkerk J.E., Pell C.L., Johnstone B.H., Considine R.V., March K.L. Secretion of angiogenic and antiapoptotic factors by human adipose stromal cells. Circulation 2004, 109:1292-1298.
29. Rehman J., Traktuev D., Li J.L., Merfeld-Clauss S., Temm-Grove C.J., Bovenkerk J.E., Pell C.L., Johnstone B.H., Considine R.V., March K.L. Secretion of angiogenic and antiapoptotic factors by human adipose stromal cells. Circulation 2004, 109:1292-1298.
30. Rosenberg P.A. Catecholamine toxicity in cerebral cortex in dissociated cell culture. J. Neurosci. 1988, 8:2887-2894.
31. Ryu H.H., Kang B.J., Park S.S., Kim Y., Sung G.J., Woo H.M., Kim W.H., Kweon O.K. Comparison of mesenchymal stem cells derived from fat, bone marrow, Wharton's jelly, and umbilical cord blood for treating spinal cord injuries in dogs. J. Vet. Med. Sci. 2012, 74:1617-1630.
32. Sadat S., Gehmert S., Song Y.H., Yen Y., Bai X., Gaiser S., Klein H., Alt E. The cardioprotective effect of mesenchymal stem cells is mediated by IGF-I and VEGF. Biochem. Biophys. Res. Commun. 2007, 363:674-679.
33. Safford K.M., Hicok K.C., Safford S.D., Halvorsen Y.D., Wilkison W.O., Gimble J.M., Rice H.E. Neurogenic differentiation of murine and human adipose-derived stromal cells. Biochem. Biophys. Res. Commun. 2002, 294:371-379.
34. Safford K.M., Safford S.D., Gimble J.M., Shetty A.K., Rice H.E. Characterization of neuronal/glial differentiation of murine adipose-derived adult stromal cells. Exp. Neurol. 2004, 187:319-328.
35. Schober A. Classic toxin-induced animal models of Parkinson's disease: 6-OHDA and MPTP. Cell Tissue Res. 2004, 318:215-224.
36. Soto-Otero R., Mendez-Alvarez E., Hermida-Ameijeiras A., Munoz-Patino A.M., Labandeira-Garcia J.L. Autoxidation and neurotoxicity of 6-hydroxydopamine in the presence of some antioxidants: potential implication in relation to the pathogenesis of Parkinson's disease. J. Neurochem. 2000, 74:1605-1612.
37. Suga H., Eto H., Shigeura T., Inoue K., Aoi N., Kato H., Nishimura S., Manabe I., Gonda K., Yoshimura K. IFATS collection: fibroblast growth factor-2-induced hepatocyte growth factor secretion by adipose-derived stromal cells inhibits postinjury fibrogenesis through a c-Jun N-terminal kinase-dependent mechanism. Stem Cells 2009, 27:238-249.
38. Sun Y., Jin K., Xie L., Childs J., Mao X.O., Logvinova A., Greenberg D.A. VEGF-induced neuroprotection, neurogenesis, and angiogenesis after focal cerebral ischemia. J. Clin. Invest. 2003, 111:1843-1851.
39. Tholpady S.S., Katz A.J., Ogle R.C. Mesenchymal stem cells from rat visceral fat exhibit multipotential differentiation in vitro. Anat. Rec. A Discov. Mol. Cell. Evol. Biol. 2003, 272:398-402.
40. Tieu K., Ischiropoulos H., Przedborski S. Nitric oxide and reactive oxygen species in Parkinson's disease. IUBMB Life 2003, 55:329-335.
41. Tiffany-Castiglioni E., Saneto R.P., Proctor P.H., Perez-Polo J.R. Participation of active oxygen species in 6-hydroxydopamine toxicity to a human neuroblastoma cell line. Biochem. Pharmacol. 1982, 31:181-188.
42. Wei X., Du Z., Zhao L., Feng D., Wei G., He Y., Tan J., Lee W.H., Hampel H., Dodel R., Johnstone B.H., March K.L., Farlow M.R., Du Y. IFATS collection: the conditioned media of adipose stromal cells protect against hypoxia-ischemia-induced brain damage in neonatal rats. Stem Cells 2009, 27:478-488.
43. Wei X., Zhao L., Zhong J., Gu H., Feng D., Johnstone B.H., March K.L., Farlow M.R., Du Y. Adipose stromal cells-secreted neuroprotective media against neuronal apoptosis. Neurosci. Lett. 2009, 462:76-79.
44. Willis G.L., Kennedy G.A. The implementation of acute versus chronic animal models for treatment discovery in Parkinson's disease. Rev. Neurosci. 2004, 15:75-87.
45. Yang L.Y., Liu X.M., Sun B., Hui G.Z., Fei J., Guo L.H. Adipose tissue-derived stromal cells express neuronal phenotypes. Chin. Med. J. (Engl.) 2004, 117:425-429.
46. Zhao L., Wei X., Ma Z., Feng D., Tu P., Johnstone B.H., March K.L., Du Y. Adipose stromal cells-conditional medium protected glutamate-induced CGNs neuronal death by BDNF. Neurosci. Lett. 2009, 452:238-240.
47. Zuk P.A., Zhu M., Ashjian P., De Ugarte D.A., Huang J.I., Mizuno H., Alfonso Z.C., Fraser J.K., Benhaim P., Hedrick M.H. Human adipose tissue is a source of multipotent stem cells. Mol. Biol. Cell 2002, 13:4279-4295.